These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 33745453

  • 1. Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature.
    Ono R, Kumagae T, Igasaki M, Murata T, Yoshizawa M, Kitagawa I.
    J Med Case Rep; 2021 Mar 22; 15(1):142. PubMed ID: 33745453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis.
    Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Jouen F, Joly P, Marie I, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O, OncoMyositis Study Group.
    Arthritis Rheumatol; 2019 Aug 22; 71(8):1360-1370. PubMed ID: 30896088
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis.
    Kotobuki Y, Tonomura K, Fujimoto M.
    Immunol Med; 2021 Mar 22; 44(1):23-29. PubMed ID: 32649853
    [Abstract] [Full Text] [Related]

  • 9. Clinical and laboratory features between anti-TIF1γ dermatomyositis with and without malignancy: 37 case series and a review.
    Tang KY, Zhang HL, Zhang XY, Jin HZ.
    J Dermatol; 2024 Dec 22; 51(12):1646-1657. PubMed ID: 39258818
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis.
    Fujimoto M, Murakami A, Kurei S, Okiyama N, Kawakami A, Mishima M, Sato S, Seishima M, Suda T, Mimori T, Takehara K, Kuwana M.
    J Dermatol Sci; 2016 Dec 22; 84(3):272-281. PubMed ID: 27693019
    [Abstract] [Full Text] [Related]

  • 13. Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive Dermatomyositis.
    Fiorentino D, Mecoli CA, Igusa T, Albayda J, Paik JJ, Tiniakou E, Adler B, Mammen AL, Shah AA, Rosen A, Christopher-Stine L, Casciola-Rosen L.
    Arthritis Rheumatol; 2023 Jul 22; 75(7):1238-1245. PubMed ID: 36762496
    [Abstract] [Full Text] [Related]

  • 14. Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies.
    Ly NTM, Ma N, Ueda-Hayakawa I, Nguyen CTH, Anada R, Okamoto H, Fujimoto M.
    J Dermatol Sci; 2021 Dec 22; 104(3):177-184. PubMed ID: 34772582
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of Anti-Transcription Intermediary Factor 1γ Antibodies With Paraneoplastic Rheumatic Syndromes Other Than Dermatomyositis.
    Venalis P, Selickaja S, Lundberg K, Rugiene R, Lundberg IE.
    Arthritis Care Res (Hoboken); 2018 Apr 22; 70(4):648-651. PubMed ID: 28704599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti-Transcriptional Intermediary Factor 1γ Juvenile-Onset Dermatomyositis.
    Sherman MA, Yang Q, Gutierrez-Alamillo L, Pak K, Flegel WA, Mammen AL, Rider LG, Casciola-Rosen LA, Childhood Myositis Heterogeneity Collaborative Study Group.
    Arthritis Rheumatol; 2024 Apr 22; 76(4):631-637. PubMed ID: 38059274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.